Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
07/10/2013 | CN103191409A Treatment of T-cell mediated diseases |
07/10/2013 | CN103191408A Medicine composition and gel for treating colpitis and applications thereof |
07/10/2013 | CN103191407A Novel use of pentapeptide and metabolite thereof in preparation of anti-dementia product |
07/10/2013 | CN103191406A Application of combination medicine to lymphoma |
07/10/2013 | CN103191405A Combination medicine containing bortezomib |
07/10/2013 | CN103191404A Medicine for treating nose bleeding and preparation method thereof |
07/10/2013 | CN103191403A Method for preparing brain protein hydrolyzate |
07/10/2013 | CN103191070A Oral tablet of superoxide dismutase and preparation method thereof |
07/10/2013 | CN103190941A Combined needling instrument and small molecular minimally invasive technology for curing ankylosing spondylitis |
07/10/2013 | CN102755289B Argatroban injection for resisting thrombus and preparation method thereof |
07/10/2013 | CN102727873B Applications of buckwheat trypsin inhibitor |
07/10/2013 | CN102698247B Glutamine dipeptide and compound amino acid medicinal composition prepared with solvent crystallization method |
07/10/2013 | CN102643762B Brevibacillus parabrevis as well as method and application of protein series prepared thereby |
07/10/2013 | CN102604960B Neurotoxin S10a of South China Sea Conus striatus, coding sequence and application of the neurotoxin |
07/10/2013 | CN102525902B High concentration pidotimod oral liquid |
07/10/2013 | CN102516366B Th1 cell factor immunoregulation polypeptide and application thereof |
07/10/2013 | CN102432670B Silkworm chrysalis protein source dipeptide SS and application thereof |
07/10/2013 | CN102329376B Cyclo(phenylalanine-N-methylleucyl-leucyl-N-methylleucyl-leucyl), and synthesis method and application thereof |
07/10/2013 | CN102203118B Peptide antagonist of interleukin-15 activity |
07/10/2013 | CN102060920B Construction of abrin A chain mutant and application as candidate vaccine antigen |
07/10/2013 | CN101816777B Novel Boanmycin composition and preparation method thereof |
07/10/2013 | CN101810560B Cyclosporine A polymeric micelles composition |
07/10/2013 | CN101810559B Hirudin polyion micelle composition of targeted platelet |
07/10/2013 | CN101754768B Survivin peptides as cancer vaccines |
07/10/2013 | CN101721691B Preparation for treating and restoring infective wound surface and preparation method thereof |
07/10/2013 | CN101678086B 固体纤维蛋白原制剂 The solid fibrinogen preparation |
07/10/2013 | CN101643511B Fusion protein for inhibiting telomerase activity, preparation and application thereof |
07/10/2013 | CN101384273B Microrna expression abnormalities in pancreatic endocrine and acinar tumors |
07/10/2013 | CN101107005B CRIg polypeptide for prevention and treatment of complement-associated disorders |
07/09/2013 | US8481686 Antibodies that bind stresscopin peptides |
07/09/2013 | US8481679 Immobilizing an entity in a desired orientation on a support material |
07/09/2013 | US8481676 Protein and production process and use thereof |
07/09/2013 | US8481599 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
07/09/2013 | US8481597 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
07/09/2013 | US8481504 Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications |
07/09/2013 | US8481499 Blockade of gamma-secretase activity to promote myelination by oligodendrocytes |
07/09/2013 | US8481498 Pharmaceutical compositions and methods |
07/09/2013 | US8481497 Therapeutic agent for cancer, and method for treatment of cancer |
07/09/2013 | US8481496 Gold (III) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents |
07/09/2013 | US8481494 Compounds for the treatment of diseases related to protein misfolding |
07/09/2013 | US8481493 Non-porous film for culturing cells |
07/09/2013 | US8481492 Fusion protein and use thereof |
07/09/2013 | US8481491 Scaffold polypeptides for heterologous peptide display |
07/09/2013 | US8481490 Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis |
07/09/2013 | US8481489 GH secretagogues and uses thereof |
07/09/2013 | US8481488 Compositions and methods for reducing the risk of preterm labor |
07/09/2013 | US8481487 Modified soluble FGF receptor Fc fusions method |
07/09/2013 | US8481486 Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-R |
07/09/2013 | US8481485 Insulin analogs |
07/09/2013 | US8481484 Cyclic heptapeptide and use of the same |
07/09/2013 | US8481483 Cyclosporin analogues |
07/09/2013 | US8481482 Prion protein based hemin binders and methods of use |
07/09/2013 | US8481481 Peptides and their use as carriers into cancer cells |
07/09/2013 | US8481480 Anti-adherent formulation including a quaternary ammonium compound and a fatty alcohol |
07/09/2013 | US8481479 Formulations of factor VIIa inhibitors and utility |
07/09/2013 | US8481478 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
07/09/2013 | US8481333 Detection of degradation products of feline NT-proBNP |
07/09/2013 | US8481255 Scytovirin domain 1 related polypeptides |
07/09/2013 | US8481089 Topical skin care formulations comprising plant extracts |
07/09/2013 | US8481076 Bariatric magnetic apparatus and method of manufacturing thereof |
07/09/2013 | US8481070 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
07/09/2013 | US8481064 Method for delivering a therapeutic agent comprising injection of microspheres |
07/09/2013 | US8481051 Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof |
07/09/2013 | US8481049 Methods for treating a wound using epidermal growth factor formulation |
07/09/2013 | US8481046 VEGF antagonist formulations for intravitreal administration |
07/09/2013 | US8481042 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents |
07/09/2013 | US8481038 Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins |
07/09/2013 | US8481031 Methods and compositions using Klotho-FGF fusion polypeptides |
07/09/2013 | US8481022 Method of treating autoimmune disease with mesenchymal stem cells |
07/09/2013 | US8481021 IL-1F5 polypeptides |
07/09/2013 | US8481003 Anti-CD74 immunoconjugates and methods |
07/09/2013 | CA2648936C Glp-1 compounds |
07/09/2013 | CA2640994C Enamel matrix protein composition for preventing or treating infection |
07/09/2013 | CA2588221C Modified chimeric polypeptides with improved pharmacokinetic properties |
07/09/2013 | CA2558583C Polymer-based compositions and conjugates of hiv entry inhibitors |
07/09/2013 | CA2556917C Process for preparing macrocyclic compounds |
07/09/2013 | CA2541840C P185neu-encoding dna and therapeutical uses thereof |
07/09/2013 | CA2537290C Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
07/09/2013 | CA2533314C Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
07/09/2013 | CA2532742C Use of a pak inhibitor for the treatment of a joint disease |
07/09/2013 | CA2527039C Grf analog compositions and their use |
07/09/2013 | CA2524403C Active variants of the il-18 binding protein and medical uses thereof |
07/09/2013 | CA2512824C Improved oral delivery of peptides |
07/09/2013 | CA2511530C Night-time oral insulin therapy |
07/09/2013 | CA2494216C Use of dendritic cells (dcs) expressing interleukin 12 (il-12) |
07/09/2013 | CA2463641C Antisense antiviral agent and method for treating ssrna viral infection |
07/09/2013 | CA2430702C Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
07/09/2013 | CA2369413C Transmembrane protein expressed in prostate and other cancers |
07/09/2013 | CA2354188C Cancer cell vaccine |
07/09/2013 | CA2349468C Factor viii polypeptide having factor viii:c activity |
07/06/2013 | CA2801540A1 Insulin receptor induced elastin production |
07/05/2013 | CA2800946A1 Crystal delta form of arginine perindopril salt, its preparation process and the pharmaceutical compounds containing same |
07/04/2013 | WO2013102211A2 Stabilized antiviral fusion helices |
07/04/2013 | WO2013102209A1 Glypican-4 based compositions and methods for treating and diagnosing insulin resistance |
07/04/2013 | WO2013102144A2 Ph20 polypeptede variants, formulations and uses thereof |
07/04/2013 | WO2013102063A1 Endopeptidase and neurotoxin combination treatment of bladder disorders |
07/04/2013 | WO2013102047A1 Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers |
07/04/2013 | WO2013101749A1 Stabilized glucagon nanoemulsions |
07/04/2013 | WO2013101724A2 Inhibition of clostridium difficile toxins |
07/04/2013 | WO2013101645A1 Compositions and methods for regulating glucose metabolism |